glp-1 drugs and crohn's disease for Disease: Current Evidence Treatment Options GLP-1 Agonists and Crohn's Disease:

PMID: 6328354

Upregulated expression of these two transporters can significantly accelerate the efflux of platinum agents from cells and reduce intracellular platinum accumulation, which not only impairs anti-tumor efficacy and mediates chemotherapy resistance, but also affects cumulative toxicity by altering the tissue distribution profile of the agents

After reading a local newspaper article, I started taking Acetyl L Carniyine for measurable anxiety and depression

While the VPA-induced ASD model effectively recapitulates neurodevelopmental and gastrointestinal phenotypes associated with prenatal environmental insults [43], we acknowledge it does not fully represent the genetic heterogeneity of human ASD